These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 31445954)
1. Practical definitions of severe versus familial hypercholesterolaemia and hypertriglyceridaemia for adult clinical practice. Garg A; Garg V; Hegele RA; Lewis GF Lancet Diabetes Endocrinol; 2019 Nov; 7(11):880-886. PubMed ID: 31445954 [TBL] [Abstract][Full Text] [Related]
2. The advantages and pitfalls of genetic analysis in the diagnosis and management of lipid disorders. Berberich AJ; Hegele RA Best Pract Res Clin Endocrinol Metab; 2023 May; 37(3):101719. PubMed ID: 36641373 [TBL] [Abstract][Full Text] [Related]
3. Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel. Santos RD; Gidding SS; Hegele RA; Cuchel MA; Barter PJ; Watts GF; Baum SJ; Catapano AL; Chapman MJ; Defesche JC; Folco E; Freiberger T; Genest J; Hovingh GK; Harada-Shiba M; Humphries SE; Jackson AS; Mata P; Moriarty PM; Raal FJ; Al-Rasadi K; Ray KK; Reiner Z; Sijbrands EJ; Yamashita S; Lancet Diabetes Endocrinol; 2016 Oct; 4(10):850-61. PubMed ID: 27246162 [TBL] [Abstract][Full Text] [Related]
4. Prevention of cardiovascular disease in patients with familial hypercholesterolaemia: The role of PCSK9 inhibitors. Pećin I; Hartgers ML; Hovingh GK; Dent R; Reiner Ž Eur J Prev Cardiol; 2017 Sep; 24(13):1383-1401. PubMed ID: 28644091 [TBL] [Abstract][Full Text] [Related]
5. High prevalence of primary dyslipidaemia in black South African patients at a tertiary hospital in northern Gauteng, South Africa. Khine AA; Marais DA S Afr Med J; 2016 Jun; 106(7):724-9. PubMed ID: 27384370 [TBL] [Abstract][Full Text] [Related]
6. Hypertriglyceridaemia: an update. Wierzbicki AS; Kim EJ; Esan O; Ramachandran R J Clin Pathol; 2022 Dec; 75(12):798-806. PubMed ID: 35710321 [TBL] [Abstract][Full Text] [Related]
7. Severe Hypertriglyceridaemia and Chylomicronaemia Syndrome-Causes, Clinical Presentation, and Therapeutic Options. Bashir B; Ho JH; Downie P; Hamilton P; Ferns G; Datta D; Cegla J; Wierzbicki AS; Dawson C; Jenkinson F; Delaney H; Mansfield M; Teoh Y; Miedzybrodzka Z; Haso H; Durrington PN; Soran H Metabolites; 2023 Apr; 13(5):. PubMed ID: 37233662 [TBL] [Abstract][Full Text] [Related]
8. Hypertriglyceridaemia due to genetic defects in lipoprotein lipase and apolipoprotein C-II. Fojo SS; Brewer HB J Intern Med; 1992 Jun; 231(6):669-77. PubMed ID: 1619390 [TBL] [Abstract][Full Text] [Related]
9. High lipoprotein(a) as a possible cause of clinical familial hypercholesterolaemia: a prospective cohort study. Langsted A; Kamstrup PR; Benn M; Tybjærg-Hansen A; Nordestgaard BG Lancet Diabetes Endocrinol; 2016 Jul; 4(7):577-87. PubMed ID: 27185354 [TBL] [Abstract][Full Text] [Related]
10. Severe familial hypercholesterolaemia: current and future management. Farnier M; Bruckert E Arch Cardiovasc Dis; 2012 Dec; 105(12):656-65. PubMed ID: 23199621 [TBL] [Abstract][Full Text] [Related]
11. Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): Expert panel recommendations and proposal of an "FCS score". Moulin P; Dufour R; Averna M; Arca M; Cefalù AB; Noto D; D'Erasmo L; Di Costanzo A; Marçais C; Alvarez-Sala Walther LA; Banach M; Borén J; Cramb R; Gouni-Berthold I; Hughes E; Johnson C; Pintó X; Reiner Ž; van Lennep JR; Soran H; Stefanutti C; Stroes E; Bruckert E Atherosclerosis; 2018 Aug; 275():265-272. PubMed ID: 29980054 [TBL] [Abstract][Full Text] [Related]
12. Hypertriglyceridaemia in adolescents may have serious complications. Korf M; Zöllner EW; Solomon GEA; Zemlin AE; Marais AD S Afr Med J; 2022 Apr; 112(5):307-312. PubMed ID: 35587241 [TBL] [Abstract][Full Text] [Related]
13. [Hyperlipoproteinemia and dyslipidemia as rare diseases. Diagnostics and treatment]. Češka R; Štulc T; Votavová L; Schwarzová L; Vaclová M; Freiberger T Vnitr Lek; 2016; 62(11):887-894. PubMed ID: 28128575 [TBL] [Abstract][Full Text] [Related]
14. The effects of probucol on plasma lipoproteins in polygenic and familial hypercholesterolaemia. Cortese C; Marenah CB; Miller NE; Lewis B Atherosclerosis; 1982 Sep; 44(3):319-25. PubMed ID: 7150396 [TBL] [Abstract][Full Text] [Related]
15. Cardiovascular risk in patients with treated familial hypercholesterolaemia and patients with severe hypertriglyceridaemia. Way BP; Ball MJ; Thorogood M; Cobbe SM; Mann JI J R Soc Med; 1986 Jul; 79(7):391-4. PubMed ID: 3746800 [TBL] [Abstract][Full Text] [Related]
16. Homozygous familial hypercholesterolaemia: update on management. France M Paediatr Int Child Health; 2016 Nov; 36(4):243-247. PubMed ID: 27967828 [TBL] [Abstract][Full Text] [Related]
17. The role of genetic testing in dyslipidaemia. Berberich AJ; Hegele RA Pathology; 2019 Feb; 51(2):184-192. PubMed ID: 30558903 [TBL] [Abstract][Full Text] [Related]
18. Long-term outcome in 53 patients with homozygous familial hypercholesterolaemia in a single centre in France. Bruckert E; Kalmykova O; Bittar R; Carreau V; Béliard S; Saheb S; Rosenbaum D; Bonnefont-Rousselot D; Thomas D; Emery C; Khoshnood B; Carrié A Atherosclerosis; 2017 Feb; 257():130-137. PubMed ID: 28131047 [TBL] [Abstract][Full Text] [Related]
19. A comparison of European and US guidelines for familial hypercholesterolaemia. Reiner Ž Curr Opin Lipidol; 2015 Jun; 26(3):215-20. PubMed ID: 25943839 [TBL] [Abstract][Full Text] [Related]
20. Severe hypertriglyceridaemia as a result of familial chylomicronaemia: the Cape Town experience. Pouwels ED; Blom DJ; Firth JC; Henderson HE; Marais AD S Afr Med J; 2008 Feb; 98(2):105-8. PubMed ID: 18350203 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]